Product
Metformin HCl XR
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Randomized, Open, Single-dose, Crossover-design, Phase I Study to Evaluate Bioequivalence After Co-administration of ALO 12.5 mg and MET XR 500 mg or Administration of CT-L01 12.5/500 mg in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-07-05